File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Effect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong
  • Basic View
  • Metadata View
  • XML View
TitleEffect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong
 
AuthorsHo, PL1
Chow, KH1
Tse, H1
Cheng, VCC1
 
KeywordsAntibiotic resistance
Antibiotic sensitivity
Bacterium examination
Bacterium isolate
Disk diffusion
 
Issue Date2012
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
 
CitationInternational journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
 
DescriptionLetters to the editor
 
ISSN0924-8579
2013 Impact Factor: 4.259
 
DOIhttp://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
 
DC FieldValue
dc.contributor.authorHo, PL
 
dc.contributor.authorChow, KH
 
dc.contributor.authorTse, H
 
dc.contributor.authorCheng, VCC
 
dc.date.accessioned2012-09-20T07:59:09Z
 
dc.date.available2012-09-20T07:59:09Z
 
dc.date.issued2012
 
dc.description.naturepostprint
 
dc.descriptionLetters to the editor
 
dc.identifier.citationInternational journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
 
dc.identifier.citeulike11382096
 
dc.identifier.doihttp://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
 
dc.identifier.epage281
 
dc.identifier.hkuros209850
 
dc.identifier.issn0924-8579
2013 Impact Factor: 4.259
 
dc.identifier.issue3
 
dc.identifier.pmid22795656
 
dc.identifier.scopuseid_2-s2.0-84864579589
 
dc.identifier.spage280
 
dc.identifier.urihttp://hdl.handle.net/10722/164415
 
dc.identifier.volume40
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
 
dc.publisher.placeNetherlands
 
dc.relation.ispartofInternational journal of antimicrobial agents
 
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in International journal of antimicrobial agents. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281. DOI: 10.1016/j.ijantimicag.2012.05.008
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.subjectAntibiotic resistance
 
dc.subjectAntibiotic sensitivity
 
dc.subjectBacterium examination
 
dc.subjectBacterium isolate
 
dc.subjectDisk diffusion
 
dc.titleEffect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Ho, PL</contributor.author>
<contributor.author>Chow, KH</contributor.author>
<contributor.author>Tse, H</contributor.author>
<contributor.author>Cheng, VCC</contributor.author>
<date.accessioned>2012-09-20T07:59:09Z</date.accessioned>
<date.available>2012-09-20T07:59:09Z</date.available>
<date.issued>2012</date.issued>
<identifier.citation>International journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281</identifier.citation>
<identifier.issn>0924-8579</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/164415</identifier.uri>
<description>Letters to the editor</description>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/ijantimicag</publisher>
<relation.ispartof>International journal of antimicrobial agents</relation.ispartof>
<rights>NOTICE: this is the author&#8217;s version of a work that was accepted for publication in International journal of antimicrobial agents. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281. DOI: 10.1016/j.ijantimicag.2012.05.008</rights>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<subject>Antibiotic resistance</subject>
<subject>Antibiotic sensitivity</subject>
<subject>Bacterium examination</subject>
<subject>Bacterium isolate</subject>
<subject>Disk diffusion</subject>
<title>Effect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong</title>
<type>Article</type>
<description.nature>postprint</description.nature>
<identifier.doi>10.1016/j.ijantimicag.2012.05.008</identifier.doi>
<identifier.pmid>22795656</identifier.pmid>
<identifier.scopus>eid_2-s2.0-84864579589</identifier.scopus>
<identifier.hkuros>209850</identifier.hkuros>
<identifier.volume>40</identifier.volume>
<identifier.issue>3</identifier.issue>
<identifier.spage>280</identifier.spage>
<identifier.epage>281</identifier.epage>
<publisher.place>Netherlands</publisher.place>
<identifier.citeulike>11382096</identifier.citeulike>
<bitstream.url>http://hub.hku.hk/bitstream/10722/164415/1/Content.pdf</bitstream.url>
</item>
Author Affiliations
  1. The University of Hong Kong